Abdominal Radiology

, Volume 43, Issue 11, pp 3117–3124 | Cite as

3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard

  • Nazanin Hajarol Asvadi
  • Sohrab Afshari MirakEmail author
  • Amirhossein Mohammadian Bajgiran
  • Pooria Khoshnoodi
  • Pornphan Wibulpolprasert
  • Daniel Margolis
  • Anthony Sisk
  • Robert E. Reiter
  • Steven S. Raman



To evaluate 3T mpMRI characteristics of transition zone and peripheral zone index prostate cancer lesions stratified by Gleason Score and PI-RADSv2 with whole mount histopathology correlation.


An institution review board-approved, HIPAA-compliant single-arm observational study of 425 consecutive men with 3T mpMRI prior to radical prostatectomy from December 2009 to October 2016 was performed. A genitourinary radiologist and a genitourinary pathologist matched all lesions detected on whole mount histopathology with lesions concordant for size and location on 3T mpMRI. Differences in clinical, MRI parameters, and histopathology between transition zone and peripheral zone were determined and analyzed with χ2 and Mann–Whitney U test. AUC was measured.


3T mpMRI detected 248/323 (76.7%) index lesions in peripheral zone and 75/323 (23.2%) in transition zone. Transition zone prostate cancer had higher median prostate-specific antigen (p = 0.001), larger tumor on 3T mpMRI (p = 0.001), lower proportions of PI-RADSv2 category 4 and 5 (p < 0.001), and lower pathological stage (p = 0.055) compared to peripheral zone prostate cancer. No significant differences were detected in prostate-specific antigen density, preoperative biopsy, and pathology Gleason Scores. After adjusting for significant variables from univariate analysis including prostate volume, tumor volume, prostate-specific antigen, PI-RADSv2 category, AUC for predicting clinically significant tumor in transition zone and peripheral zone were 0.80 and 0.72, respectively (p = 0.36).


The diagnostic performance of PI-RADSv2 for clinically significant transition and peripheral zone prostate cancer was similar. However, there was a lower portion of PI-RADSv2 4 and 5 lesions in transition zone compared to peripheral zone.


Prostate cancer Multiparametric magnetic resonance imaging PI-RADSv2 Gleason score 



We are grateful to Mark DeMars, William Hsu, Wenchao Tao, and Cleo Maehara who support our research. Statistical analyses for this research were supported by NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR001881. We are also thankful to Tristan R. Grogan for his statistical analyses support.

Compliance with ethical standards

Financial disclosure

The study was supported in part by the department of Radiology and Pathology Integrated Diagnostics (IDx) program and specialized program of research excellence (SPORE) of PCa.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was performed in accordance with the 1996 Health Information Portability and Accountability Act (HIPAA) and under waiver of informed consent by the institutional review board (IRB).

Informed consent

For this type of study formal consent is not required.


  1. 1.
    Key statistics for prostate cancer (2015) Accessed 29 April 2016
  2. 2.
    Early Detection of Prostate Cancer: AUA Guidelines. Accessed 28 April 2016
  3. 3.
    Haider MA, van der Kwast TH, Tanguay J, et al. (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189(2):323–328. CrossRefPubMedGoogle Scholar
  4. 4.
    Engelbrecht MR, Huisman HJ, Laheij RJ, et al. (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229(1):248–254. CrossRefPubMedGoogle Scholar
  5. 5.
    Le JD, Tan N, Shkolyar E, et al. (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67(3):569–576. CrossRefPubMedGoogle Scholar
  6. 6.
    Delongchamps NB, Rouanne M, Flam T, et al. (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107(9):1411–1418. CrossRefPubMedGoogle Scholar
  7. 7.
    Hoeks CM, Hambrock T, Yakar D, et al. (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266(1):207–217. CrossRefPubMedGoogle Scholar
  8. 8.
    Vos EK, Kobus T, Litjens GJ, et al. (2015) Multiparametric magnetic resonance imaging for discriminating low-grade from high-grade prostate cancer. Invest Radiol 50(8):490–497. CrossRefPubMedGoogle Scholar
  9. 9.
    Tan N, Lin WC, Khoshnoodi P, et al. (2016) In-Bore 3-T MR-guided transrectal targeted prostate biopsy: prostate imaging reporting and data system version 2-based diagnostic performance for detection of prostate cancer. Radiology. 283:130–139. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Garcia JJ, Al-Ahmadie HA, Gopalan A, et al. (2008) Do prostatic transition zone tumors have a distinct morphology? Am J Surg Pathol 32(11):1709–1714. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. (2016) Interobserver reproducibility of the PI-RADS version 2 Lexicon: a multicenter study of six experienced prostate radiologists. Radiology. 280(3):793–804CrossRefGoogle Scholar
  12. 12.
    American College of R PIRADS v2 (2014) Reston, Va: American College of RadiologyGoogle Scholar
  13. 13.
    Varma M, Morgan JM (2010) The weight of the prostate gland is an excellent surrogate for gland volume. Histopathology 57(1):55–58. CrossRefPubMedGoogle Scholar
  14. 14.
    Lee JJ, Thomas IC, Nolley R, et al. (2015) Biologic differences between peripheral and transition zone prostate cancer. Prostate 75(2):183–190. CrossRefPubMedGoogle Scholar
  15. 15.
    Noguchi M, Stamey TA, Neal JE, Yemoto CE (2000) An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163(6):1751–1755CrossRefGoogle Scholar
  16. 16.
    Muller BG, Shih JH, Sankineni S, et al. (2015) Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 277(3):741–750. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Nazanin Hajarol Asvadi
    • 1
  • Sohrab Afshari Mirak
    • 1
    Email author
  • Amirhossein Mohammadian Bajgiran
    • 1
  • Pooria Khoshnoodi
    • 1
  • Pornphan Wibulpolprasert
    • 2
  • Daniel Margolis
    • 3
  • Anthony Sisk
    • 4
  • Robert E. Reiter
    • 5
  • Steven S. Raman
    • 1
    • 5
  1. 1.Department of Radiological SciencesDavid Geffen School of Medicine at UCLALos AngelesUSA
  2. 2.Department of RadiologyRamathibodi HospitalBangkokThailand
  3. 3.Department of RadiologyWeill Cornell Imaging, NewYork-PresbyterianNew YorkUSA
  4. 4.Department of PathologyDavid Geffen School of Medicine at UCLALos AngelesUSA
  5. 5.Department of UrologyDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations